n-acetyl l-carnitine and kidney Carnitine Deficiency in Chronic Disease: Pathophysiology, Clinical Implications, Therapeutic Perspectives L-carnitine and Acetyl-L Carnitine: A

The complexity of microbial species and influencing factors may account for the discrepancies observed in the literature, emphasizing the value of extensive longitudinal human studies and pointing to the necessity of a multi-omic approach that integrates diverse datasets from multiple sources rather than focusing solely on one factor

doi: 10.1017/S000711450769936X 43

& Fromenty, B

African Traditional Medicine: South African Perspective

A clinical study to track the rate of disease progression with and without NAC treatment would need a longitudinal follow-up spanning years (e.g., for rapidly progressing disorders such as cALD) or decades (e.g., for slower-progressing conditions such as GD1 or AMN)

Convective airflow was provided by an industrial fan (FS-75, FWL, Auckland, NZ)